Multiplex Immunofluorescence and Multispectral Imaging: Forming the Basis of a Clinical Test Platform for Immuno-Oncology

被引:33
|
作者
Hoyt, Clifford C. [1 ]
机构
[1] Akoya Biosci Inc, Malborough, MA USA
关键词
Predictive biomarkers; multiplex immunofluorescence; multispectral imaging; immuno-oncology; clinical workflow; image analysis; automated staining; spatial biology; LUNG-CANCER; EXPRESSION; ASSAY; IMMUNOHISTOCHEMISTRY; REPRODUCIBILITY; ASSOCIATION; NSCLC;
D O I
10.3389/fmolb.2021.674747
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As immuno-oncology (I/O) emerges as an effective approach in the fight against cancer, multispectral imaging of multiplex immunofluorescence (mIF) is maturing as an analytical platform. The timing is fortuitous. Due to health economic considerations surrounding the use of I/O, there is an urgent need for tests that accurately predict response to the growing list of available therapies. Multispectral mIF provides several advantages over other biomarker modalities by enabling deeper interrogation of the intricate biology within the tumor microenvironment, including detection of cell-to-cell spatial interactions that correlate with clinical outcomes. It also provides a practical path for generating reliable and reproducible results in a clinically suitable, high-throughput workflow. In this article, we (1) describe the principles behind multispectral mIF; (2) provide advice and recommendations on assay development and optimization and highlight characteristics of a well-performing assay; and (3) discuss the requirements for translating this approach into clinical practice.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Challenges associated with the integration of immuno-oncology agents in clinical practice
    Lazure, Patrice
    Parikh, Aparna R.
    Ready, Neal E.
    Davies, Marianne J.
    Peloquin, Sophie
    Caterino, Jeffrey M.
    Lewandowski, Robert
    Lazar, Alexander J.
    Murray, Suzanne
    BMC MEDICAL EDUCATION, 2022, 22 (01)
  • [32] Clinical Advances in Immuno-oncology - Progress Towards Selective Cure
    Liu, Xin
    Belani, Chandra P.
    CURRENT MOLECULAR PHARMACOLOGY, 2016, 9 (03) : 182 - 182
  • [33] Implementation of a Clinical Immuno-Oncology Panel for Pediatric Brain Tumors
    Levine, A.
    Das, A.
    Hawkins, C.
    Johnson, M.
    Laxer, B.
    Milos, S.
    Nobre, L.
    Ryall, S.
    Siddaway, R.
    Tabori, U.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S129 - S129
  • [34] Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities
    Baik, Christina S.
    Rubin, Eric H.
    Forde, Patrick M.
    Mehnert, Janice M.
    Collyar, Deborah
    Butler, Marcus O.
    Dixon, Erica L.
    Chow, Laura Q. M.
    CLINICAL CANCER RESEARCH, 2017, 23 (17) : 4992 - 5002
  • [35] Characterization of inflammatory cell patterns and densities using multiplex immunohistochemistry immuno-oncology assays
    Dauffenbach, Lisa M.
    Kerfoot, Christopher A.
    Sia, Gela
    Masci, Anthony
    Zimmermann, Johannes
    Lesniak, Jan
    Budco, Alexei
    Lippok, Svenja
    Schneider, Katrin
    Korn, Rene
    Wiestler, Tobias
    Medrikova, Dasa
    Leiss, Florian
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [36] Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma
    Xie, Youheng
    Olkhov-Mitsel, Ekaterina
    Alminawi, Samira
    Slodkowska, Elzbieta
    Downes, Michelle R.
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 226
  • [37] Development and validation of a phenotypic screening platform for the identification of novel immuno-oncology targets
    Rabolli, Virginie
    Martini, Murielle
    Scoumanne, Ariane
    Letellier, Marie-Claire
    Crosignani, Stefano
    Queva, Christophe
    Detheux, Michel
    Swiercz, Jakub M.
    Cauwenberghs, Sandra
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [38] PET imaging of biomarkers in immuno-oncology for response prediction and treatment monitoring
    Nielsen, Carsten H.
    Kristensen, Lotte K.
    Christensen, Camilla
    Kjaer, Andreas
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [39] Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials
    Salawu, Abdulazeez
    Hernando-Calvo, Alberto
    Chen, Rachel Y.
    Araujo, Daniel, V
    Oliva, Marc
    Liu, Zhihui A.
    Siu, Lillian L.
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : 167 - 177
  • [40] Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review
    Najafi, Masoumeh
    Jahanbakhshi, Amin
    Ghersi, Sebastiano Finocchi
    Giaccherini, Lucia
    Botti, Andrea
    Cavallieri, Francesco
    Rossi, Jessica
    Iori, Federico
    Iotti, Cinzia
    Ciammella, Patrizia
    Nabiuni, Mohsen
    Gomar, Marzieh
    Rezaie, Omid
    Cozzi, Salvatore
    BRAIN SCIENCES, 2023, 13 (02)